Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063558497> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2063558497 abstract "Introduction Aprepitant is a NK1 receptor antagonist licensed for treatment of nausea and vomiting (n&v) associated with emetogenic chemotherapy. There are case reports of use for n&v post-operatively or secondary to diabetic gastroparesis. There is no published evidence in patients with cystic fibrosis (CF). Tigecycline is used in treatment of Non-Tuberulosis Mycobacteria in CF. However uncontrolled n&v can result in dose reduction, interruption or discontinuation, and treatment failure. Aims To evaluate the efficiacy and side-effects of aprepitant (added to domperidone and ondansetron) in CF patients requiring tigecycline treatment. Methods Retrospective and prospective audits (studies) were conducted with case note review of consecutive CF patients receiving IV tigecycline, using a standardised proforma. Consecutive admissions for IV tigecycline therapy were consented and commenced on aprepitant 80mg OD for the first five days of tigecycline therapy. They completed daily n&v and side-effect diaries. Results 16 case notes were evaluated retrospectively and 10 patients prospectively audited. Aprepitant was likely to have contributed to reduction in nv all resolved on continuing aprepitant or persisted despite stopping aprepitant. Conclusion(s) Aprepitant was well tolerated and appeared to be effective for a number of CF patients. Ongoing work will further evaluate the benefit of aprepitant in this population and inform clinical guidelines for management of n&v in CF patients." @default.
- W2063558497 created "2016-06-24" @default.
- W2063558497 creator A5027376522 @default.
- W2063558497 creator A5055576299 @default.
- W2063558497 creator A5076460433 @default.
- W2063558497 creator A5078963135 @default.
- W2063558497 creator A5081706156 @default.
- W2063558497 date "2015-03-01" @default.
- W2063558497 modified "2023-09-23" @default.
- W2063558497 title "USE OF APREPITANT AS AN ANTIEMETIC IN CYSTIC FIBROSIS PATIENTS" @default.
- W2063558497 doi "https://doi.org/10.1136/bmjspcare-2014-000838.43" @default.
- W2063558497 hasPublicationYear "2015" @default.
- W2063558497 type Work @default.
- W2063558497 sameAs 2063558497 @default.
- W2063558497 citedByCount "0" @default.
- W2063558497 crossrefType "journal-article" @default.
- W2063558497 hasAuthorship W2063558497A5027376522 @default.
- W2063558497 hasAuthorship W2063558497A5055576299 @default.
- W2063558497 hasAuthorship W2063558497A5076460433 @default.
- W2063558497 hasAuthorship W2063558497A5078963135 @default.
- W2063558497 hasAuthorship W2063558497A5081706156 @default.
- W2063558497 hasBestOaLocation W20635584971 @default.
- W2063558497 hasConcept C126322002 @default.
- W2063558497 hasConcept C2777170512 @default.
- W2063558497 hasConcept C2778715236 @default.
- W2063558497 hasConcept C2780574406 @default.
- W2063558497 hasConcept C2780580376 @default.
- W2063558497 hasConcept C2780852908 @default.
- W2063558497 hasConcept C2780884295 @default.
- W2063558497 hasConcept C42219234 @default.
- W2063558497 hasConcept C71924100 @default.
- W2063558497 hasConceptScore W2063558497C126322002 @default.
- W2063558497 hasConceptScore W2063558497C2777170512 @default.
- W2063558497 hasConceptScore W2063558497C2778715236 @default.
- W2063558497 hasConceptScore W2063558497C2780574406 @default.
- W2063558497 hasConceptScore W2063558497C2780580376 @default.
- W2063558497 hasConceptScore W2063558497C2780852908 @default.
- W2063558497 hasConceptScore W2063558497C2780884295 @default.
- W2063558497 hasConceptScore W2063558497C42219234 @default.
- W2063558497 hasConceptScore W2063558497C71924100 @default.
- W2063558497 hasLocation W20635584971 @default.
- W2063558497 hasOpenAccess W2063558497 @default.
- W2063558497 hasPrimaryLocation W20635584971 @default.
- W2063558497 hasRelatedWork W1974194880 @default.
- W2063558497 hasRelatedWork W1985217654 @default.
- W2063558497 hasRelatedWork W1988900492 @default.
- W2063558497 hasRelatedWork W2007565764 @default.
- W2063558497 hasRelatedWork W2022787348 @default.
- W2063558497 hasRelatedWork W2027870025 @default.
- W2063558497 hasRelatedWork W2033905901 @default.
- W2063558497 hasRelatedWork W2043679431 @default.
- W2063558497 hasRelatedWork W2065258017 @default.
- W2063558497 hasRelatedWork W2075857733 @default.
- W2063558497 hasRelatedWork W2096279367 @default.
- W2063558497 hasRelatedWork W2149837886 @default.
- W2063558497 hasRelatedWork W2252931906 @default.
- W2063558497 hasRelatedWork W2312964118 @default.
- W2063558497 hasRelatedWork W2783885406 @default.
- W2063558497 hasRelatedWork W2791900435 @default.
- W2063558497 hasRelatedWork W2794474917 @default.
- W2063558497 hasRelatedWork W2889848726 @default.
- W2063558497 hasRelatedWork W2996099006 @default.
- W2063558497 hasRelatedWork W3029783972 @default.
- W2063558497 isParatext "false" @default.
- W2063558497 isRetracted "false" @default.
- W2063558497 magId "2063558497" @default.
- W2063558497 workType "article" @default.